Genomics Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.30 M
as on 09-07-2024
- Paid Up Capital ₹ 0.50 M
as on 09-07-2024
- Company Age 11 Year, 5 Days
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 0.95 M
as on 09-07-2024
- Revenue 30.29%
(FY 2020)
- Profit 67.23%
(FY 2020)
- Ebitda 64.96%
(FY 2020)
- Net Worth 2.66%
(FY 2020)
- Total Assets 27.77%
(FY 2020)
About Genomics Healthcare
The Company is engaged in the Fashion And Textile Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.30 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.95 M.
Someswar Palit and Banani Palit serve as directors at the Company.
- CIN/LLPIN
U85100WB2013PTC199130
- Company No.
199130
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2013
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Howrah, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Genomics Healthcare Private Limited offer?
Genomics Healthcare Private Limited offers a wide range of products and services, including Calcium Tablet, Calcium Citrate and Vitamin D3 Tablet, Nutritional Supplements, Multivitamin Supplements, Pharmaceutical Medicine, Lycopene Syrup.
Who are the key members and board of directors at Genomics Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Someswar Palit  | Director | 19-Dec-2013 | Current |
| Banani Palit | Director | 19-Dec-2013 | Current |
Financial Performance of Genomics Healthcare.
Genomics Healthcare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 30.29% increase. The company also saw a substantial improvement in profitability, with a 67.23% increase in profit. The company's net worth moved up by a moderate rise of 2.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genomics Healthcare?
In 2020, Genomics Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 30 May 2020 | ₹0.15 M | Open |
Others Creation Date: 29 Mar 2019 | ₹0.80 M | Open |
How Many Employees Work at Genomics Healthcare?
Unlock and access historical data on people associated with Genomics Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genomics Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomics Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
